Overview

• The peer-reviewed study introducing MARQO appears in Nature Biomedical Engineering from a team led by Sacha Gnjatic, PhD.
• MARQO processes entire tumor slides without patching and completes analyses in minutes on standard GPUs.
• The system supports common immunohistochemistry and immunofluorescence staining technologies to improve cross-study reproducibility.
• It automatically flags likely positive cells with recorded coordinates and marker intensities, leaving final validation to pathologists.
• The developers plan user interface upgrades, advanced spatial and neighborhood analyses, and high-performance computing scaling, and they note MARQO is for research use only and not validated for clinical diagnostics.